共 76 条
[1]
Jayasinghe K., Stark Z., Kerr P.G., Gaff C., Martyn M., Whitlam J., Creighton B., Donaldson E., Hunter M., Jarmolowicz A., Johnstone L., Krzesinski E., Lunke S., Lynch E., Nicholls K., Patel C., Prawer Y., Ryan J., See E.J., Talbot A., Trainer A., Tytherleigh R., Valente G., Wallis M., Wardrop L., West K.H., White S.M., Wilkins E., Mallett A.J., Quinlan C., Clinical impact of genomic testing in patients with suspected monogenic kidney disease, Genet Med, 23, pp. 183-191, (2021)
[2]
Chen J., Lin F., Zhai Y., Wang C., Wu B., Ma D., Rao J., Liu J., Liu J., Yu M., Shen Q., Xu H., Diagnostic and clinical utility of genetic testing in children with kidney failure, Pediatr Nephrol, 36, pp. 3653-3662, (2021)
[3]
Dahl N.K., Bloom M.S., Chebib F.T., Clark D., Westemeyer M., Jandeska S., Zhang Z., Milo-Rasouly H., Kolupaeva V., Marasa M., Broumand V., Fatica R.A., Raj D.S., Demko Z.P., Marshall K., Punj S., Tabriziani H., Bhorade S., Gharavi A.G., The clinical utility of genetic testing in the diagnosis and management of adults with chronic kidney disease, J Am Soc Nephrol, 34, pp. 2039-2050, (2023)
[4]
Groopman E.E., Marasa M., Cameron-Christie S., Petrovski S., Aggarwal V.S., Milo-Rasouly H., Li Y., Zhang J., Nestor J., Krithivasan P., Lam W.Y., Mitrotti A., Piva S., Kil B.H., Chatterjee D., Reingold R., Bradbury D., DiVecchia M., Snyder H., Mu X., Mehl K., Balderes O., Fasel D.A., Weng C., Radhakrishnan J., Canetta P., Appel G.B., Bomback A.S., Ahn W., Uy N.S., Alam S., Cohen D.J., Crew R.J., Dube G.K., Rao M.K., Kamalakaran S., Copeland B., Ren Z., Bridgers J., Malone C.D., Mebane C.M., Da
[5]
Genome UK: 2022 to 2025 Implementation Plan for England, (2022)
[6]
Manolio T.A., Abramowicz M., Al-Mulla F., Anderson W., Balling R., Berger A.C., Bleyl S., Chakravarti A., Chantratita W., Chisholm R.L., Dissanayake V.H.W., Dunn M., Dzau V.J., Han B.-G., Hubbard T., Kolbe A., Korf B., Kubo M., Lasko P., Leego E., Mahasirimongkol S., Majumdar P.P., Matthijs G., McLeod H.L., Metspalu A., Meulien P., Miyano S., Naparstek Y., O'Rourke P.P., Patrinos G.P., Rehm H.L., Relling M.V., Rennert G., Rodriguez L.L., Roden D.M., Shuldiner A.R., Sinha S., Tan P., Ulfendahl M
[7]
Accelerating Access to Genomics for Global Health: Promotion, Implementation, Collaboration, and Ethical, Legal, and Social Issues: A Report of the WHO Science Council, (2022)
[8]
Barwell J., Snape K., Wedderburn S., The new genomic medicine service and implications for patients, Clin Med (Lond), 19, pp. 273-277, (2019)
[9]
Best S., Long J.C., Gaff C., Braithwaite J., Taylor N., Organizational perspectives on implementing complex health interventions: clinical genomics in Australia, J Health Organ Manag, 35, pp. 825-845, (2021)
[10]
Best S., Vidic N., An K., Collins F., White S.M., A systematic review of geographical inequities for accessing clinical genomic and genetic services for non-cancer related rare disease, Eur J Hum Genet, 30, pp. 645-652, (2022)